|
|||
The Risk of Upper Urinary Tract Involvement in Patients With Ketamine-Associated Uropathy
Chi-Hang Yee, Jeremy Yuen-Chun Teoh, Pui-Tak Lai, Vivian Yee-Fong Leung, Winnie Chiu-Wing Chu, Wai-man Lee, Yuk-Him Tam, Chi-Fai Ng
Int Neurourol J. 2017;21(2):128-132. Published online 2017 Jun 21
DOI: https://doi.org/10.5213/inj.1732704.352 |
|||
Citations to this article as recorded by Ketamine cystitis following ketamine therapy for treatment-resistant depression – case report
Minna Chang, Mario F Juruena, Allan H Young
BMC Psychiatry.2024;[Epub] CrossRef Ketamine-Induced Sclerosing Cholangitis Associated With Early Inflammatory Bowel Disease During Chronic Topical Ketamine Use
Gerond Lake-Bakaar, Benjamin Milgrom, Clark Kulig, Andrea K. Sotelo, Joselle Speirs, Alexandra Meihofer
Gastro Hep Advances.2024; 3(4): 471. CrossRef British Association of Urological Surgeons Consensus statements on the management of ketamine uropathy
Mohammed Belal, Alison Downey, Ruth Doherty, Ased Ali, Hashim Hashim, Andy Kozan, Magda Kujawa, Mahreen Pakzad, Tina Rashid, Nadir Osman, Arun Sahai, Suzanne Biers
BJU International.2024; 134(2): 148. CrossRef Ketamine associated upper urinary tract dysfunction: What we know from current report?
Zhihuan Zheng, Zhongyi Li, Jiazhe Yuan, Feng Han, Li Huang, Zhao Wang
Asian Journal of Urology.2024;[Epub] CrossRef Can We Better Understand, Diagnose, and Treat Ketamine‐Induced Uropathy, and Can It Be Reversed? ICI‐RS 2024
François Hervé, Patrik Aronsson, D. Carolina Ochoa, Gommert Van Koeveringe, Giovanni Mosiello, Marcio Augusto Averbeck, George Bou Kheir, Michel Wyndaele, Paul Abrams
Neurourology and Urodynamics.2024;[Epub] CrossRef Current approaches for the treatment of ketamine‐induced cystitis
Juan Zhou, Cassidy Scott, Ziba Rovei Miab, Christian Lehmann
Neurourology and Urodynamics.2023; 42(3): 680. CrossRef Themapoli voor ketamine-geïnduceerde cystitis: eerste ervaringen en resultaten
Wouter M. H. van der Sanden, Michel Wyndaele, Robert A. Schipper, Laetitia M. O. de Kort
Tijdschrift voor Urologie.2023;[Epub] CrossRef Ketamine uropathy: Clinical experience in a high prevalence center
George Sturgess, Ian Beckley, Robin Shepherd, Alison Downey
Neurourology and Urodynamics.2023; 42(7): 1555. CrossRef Toxicity and postwithdrawal effects of ketamine on the reproductive function of male albino rats: Hormonal, histological, and immunohistochemical study
MG Paulis, EM Hafez, NF El-Tahawy
Human & Experimental Toxicology.2020; 39(8): 1054. CrossRef What urologists need to know about ketamine‐induced uropathy: A systematic review
Daniele Castellani, Giacomo M. Pirola, Marilena Gubbiotti, Emanuele Rubilotta, Kalyan Gudaru, Andrea Gregori, Marco Dellabella
Neurourology and Urodynamics.2020; 39(4): 1049. CrossRef Risk of Renal Function Decline in Patients with Ketamine-Associated Uropathy
Shih-Hsiang Ou, Ling-Ying Wu, Hsin-Yu Chen, Chien-Wei Huang, Chih-Yang Hsu, Chien-Liang Chen, Kang-Ju Chou, Hua-Chang Fang, Po-Tsang Lee
International Journal of Environmental Research and Public Health.2020; 17(19): 7260. CrossRef Epidemiologic characteristics and risk factors in patients with ketamine-associated lower urinary tract symptoms accompanied by urinary tract infection
Weihua Liu, Weiwei Wu, Yongbao Wei, Jinfeng Wu, Tao Li, Qingguo Zhu, Liefu Ye, Fuyuan Hong, Yunliang Gao, Jinrui Yang
Medicine.2019; 98(23): e15943. CrossRef
|